India's Cadila to end late-stage trials of potential Covid-19 vaccine in March 2021

Representative image/Credit: Pixabay Image

India's Zydus Cadila plans to complete late-stage trials for its potential coronavirus vaccine in March 2021 and could produce up to 100 million doses a year if trials are successful, Chairman Pankaj Patel told Reuters told Reuters.

CORONAVIRUS SPECIAL COVERAGE ONLY ON DH

Cadila's vaccine candidate, dubbed ZyCov-D, is one of dozens being developed around the world to fight the coronavirus.

Deccan Herald is on WhatsApp Channels| Join now for Breaking News & Editor's Picks